Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.
Angiotensin converting enzyme inhibitors and AT1 receptor antagonists have been proven to reduce morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function.
Pasquale Ferrone Filardi is an Associate Professor of Cardiology and head of the Cardiology School at the University of Naples, Italy.
Pathogenetic mechanisms of RAS involvement in cardiovascular diseases.- Antiotensin converting enzyme inhibitors and at1 antagonists for treatment of hypertension.- Renin angiotensin system antagonism in heart failure.- Impact of co-morbidities on RAS inhibitors choice in hypertensive and heart failure patients.- Target organ damage and RAS blockade.